Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Hep C Drugs May Cause Liver Failure Risks: ISMP Report January 26, 2017 Irvin Jackson Add Your Comments A new report raises serious questions about the safety and side effects of the hepatitis C Sovaldi, Harvoni, Viekira Pak, and Olysio, which could increase the risk of acute liver failure, hepatitis B reactivation and death. The Institute for Safe Medication Practices (ISMP) issued its Quarterwatch (PDF) report this week, indicating that the FDA has noticed a number of safety signals with direct-acting antiviral drugs, which are a relatively new type of hepatitis C drug. The medications have already linked to more than 1,500 reports of liver failure or severe liver injury, and could cause dormant hepatitis B viruses to become active again, the report warns. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION After examining adverse event reports involving the new class of drugs, which first began appearing on the market in November 2013, ISMP researchers determined that more than 1,500 reports of liver failure or severe liver injury have already been reported, and the drugs could cause dormant hepatitis B viruses to become active again. The drugs may suppress the hepatitis C virus to undetectable levels in just 12 weeks, compared to 26 weeks for older drugs, and in most cases appear to cure it, completely eliminating detectable virus levels in 89% to 100% in the clinical trials. However, in an investigation of the last year’s FDA adverse event reports, ISMP found 524 case of liver failure linked to the drugs, as well as 1,058 incidents of severe liver injury. Additionally, the report indicates that there were 761 cases where the drugs failed to work over the last year’s worth of available data. The FDA also received 24 reports of hepatitis B reactivation. “The 524 reported cases of liver failure included all the approved direct-acting antivirals as either primary or secondary suspect drugs, often in combination with each other or with ribavirin,” the ISMP report notes. “Almost half the cases also included the hallmark symptom of liver failure, encephalopathy, which is a form of brain injury resulting in delirium, personality changes, suicidal behavior, sleep-wake reversal, and coma. Overall, 165 (31.5%) had died at the time of the report.” Vikekira Pak was associated with the highest percentage of liver failure cases, accounting for 34.5%, followed by Solvadi, at 32%, and Harvoni at 23.1%. Other drugs the report looked at included Daklinza, which accounted for 18.9% of liver failure cases, Olysio, which accounted for only 7.1%, and Zepatier, which was only linked to 1 case (0.2%). The numbers may not be reflective of the actual comparative risk, as some of the drugs are far more widely prescribed than the others. The first major safety signal linked to the drugs occurred in October 2016, when the FDA issued a hepatitis C drug warning, indicating that it had received reports of hepatitis B reactivation. The FDA required the drugs to add a black box warning, the strongest warning the agency can require a drug to carry. The FDA first began receiving hepatitis B reactivation problems in November 2013, and as of July 2016, has received a total of 24 cases of hepatitis B infections following patients receiving direct-acting antiviral treatments. Of the 24 reported cases, hepatitis B reactivation usually occurred within 4-8 weeks of receiving treatment. To date, of the 24 patients known to suffer hepatitis B reactivations from the use of direct-acting antiviral medications, one required a liver transplant and two others died. The 21 other cases were treated by medical professionals to reduce the expansion and symptoms of the infection. In most case of acute hepatitis B infection, patients have mild symptoms of abdominal pain, yellowing of the eyes, and darkened urine. However, a small portion of individuals develop severe life-threatening forms of chronic hepatitis B that lasts longer than six months, putting them at increased risks of death from cirrhosis and liver cancer, often resulting in the need for a liver transplant. According to the World Health Organization (WHO), an estimated 240 million individuals across the world have hepatitis B, and on average 686,000 die annually from the result of chronic liver damage and liver cancer. According to the ISMP report, about 2 million to 3 million people in the U.S. suffer hepatitis C infections, but they can go undetected for decades due to a lack of symptoms, and can result in cirrhosis and liver cancer. The cost of the drugs has been a public issue over the last couple years, with costs reaching as high as $125,000 for a treatment regimen. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Harvoni, Hepatitis, Hepatitis B, Hepatitis C, Liver Failure, Liver Injury, Olysio, Sovaldi, Viekira Pak More Lawsuit Stories Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns August 29, 2025 MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers August 29, 2025 Hyperbaric Oxygen Chamber Fires, Injuries Lead to New FDA Safety Recommendations August 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermX/TwitterThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (Posted: yesterday) A lawsuit filed over an Amazon fire pit explosion claims a Canadian woman suffered second and third-degree burns due to the device’s dangerous design. MORE ABOUT: TABLETOP FIRE PIT LAWSUITTabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)Alcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025) DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: 2 days ago) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025) Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: 3 days ago) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)
Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns August 29, 2025
Amazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (Posted: yesterday) A lawsuit filed over an Amazon fire pit explosion claims a Canadian woman suffered second and third-degree burns due to the device’s dangerous design. MORE ABOUT: TABLETOP FIRE PIT LAWSUITTabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)Alcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025)
DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: 2 days ago) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025)
Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: 3 days ago) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)